Treating transcriptional addiction in small cell lung cancer
- PMID: 25490443
- DOI: 10.1016/j.ccell.2014.11.012
Treating transcriptional addiction in small cell lung cancer
Abstract
Small cell lung cancer (SCLC) is a devastating tumor type with great therapeutic need. In this issue of Cancer Cell, Christensen and colleagues identify THZ1, a CDK7 inhibitor, as a potential therapy for SCLC. Using cells and mouse models, the authors show exquisite sensitivity of SCLC to transcriptional inhibition.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment on
-
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.Cancer Cell. 2014 Dec 8;26(6):909-922. doi: 10.1016/j.ccell.2014.10.019. Cancer Cell. 2014. PMID: 25490451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
